Following what can only be described as a regulatory war of attrition over the past six years and more, the forced evolution of CLO structures, as numerous tedious regulatory initiatives have been imposed, has brought ever mounting responsibility for directors in the new era of CLO 3.0.

With no slowdown in the relentless pace of regulatory change, traditionally more passive CLO directors have now effectively become regulatory gatekeepers, requiring an immense level of in-depth knowledge to ensure compliance, as well as increased time commitment and greater experience, to handle the numerous issues that continue to arise throughout the life of a CLO transaction.

CONTACTS

bioImage

Guy Major

Global Head of Fiduciary Services

+1 345 814 5818

bioImage

Andrew Dean

Senior Vice President

+1 345 814 5710

*
*
*
*


Please note that your email may be received and read by other Maples Group employees in addition to your intended recipient.

The use of this form does not create an attorney-client relationship and information submitted will not necessarily be treated as privileged or confidential, nor will it prevent us from accepting related instructions on behalf of others. Do not send us any information regarding any current or potential legal matters until your proposed engagement of us as legal counsel has been agreed and confirmed by us in writing.

*
*
*

Please note that your email may be received and read by other Maples Group employees in addition to your intended recipient.

Connect

Want to get in touch ?

Contact Us